FREE Breaking News Alerts from StreetInsider.com!
E-mail Address
Top NewsMost Read Highlighted
Get AlertsARNA Hot Sheet
NEUTRAL ( Down)
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is seeing activity after its Lorcaserin was proposed for DEA Schedule IV placement. Link
The Drug Enforcement Administration (DEA) proposes placing the substance lorcaserin, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, into Schedule IV of the Controlled Substances Act (CSA).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items – JOIN NOW